SECOND AMENDMENT TO EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • January 30th, 2015 • Capstone Therapeutics Corp. • Pharmaceutical preparations
This Second Amendment to Exclusive License Agreement (this “Second Amendment”) is made effective as of December 15, 2014 (the “Second Amendment Effective Date”) by and between The UAB Research Foundation (“UABRF”) and LipimetiX Development, LLC (“Licensee”). For purposes of this Second Amendment, each of UABRF and Licensee is referred to herein as a “Party” and collectively, they are referred to as the “Parties”.
